Skip to Main Content

Paper Details

Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia.
Leuk Lymphoma
0
2023
Author NameAffiliation
Jalpa A DoshiPerelman School of Medicine, University of Pennsylvania
  • 1 - 1

Datasets

Release 1.2